Intermediate for Empagliflozin. Empagliflozin (trade name: Jardiance) is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2). Empagliflozin is used for the treatment of type 2 diabetes in adults. Empagliflozin has been approved by the U.S Food and Drug Administration on August 1, 2014.


Product Name:                  (2-Chloro-5-iodophenyl)(4-fluorophenyl)methanone

Synonyms:                         N/A

CAS Number:                     915095-86-2

Molecular Weight:            360.5536

Molecular Formula:          C13H7ClFIO

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               Fc1ccc(cc1)C(=O)c1cc(I)ccc1Cl

  • $69.00
  • Ex Tax: $69.00

Available Options